Analyst firms · Raymond James · ALNY
Raymond James ALNY price target and rating history
Alnylam Pharmaceuticals Inc. (ALNY) · Health Care
Raymond James rates Alnylam Pharmaceuticals Inc. (ALNY) Outperform with a $315 price target, as of its latest action on Oct 30, 2026. It has published 4 rating actions on ALNY since September 2023, including 1 upgrade and 1 downgrade. Across 10 firms with a ALNY price target in the last 12 months, the median target is $324. Raymond James's $315 is 3% below that.
- Current rating
- Outperform
- Price target
- $315
- Median target, all firms
- $324
- Actions on ALNY
- 4
Raymond James price target on ALNY
Every Raymond James rating on ALNY
- Oct 30, 2026
- Aug 3, 2026
- Jul 30, 2025
- Sep 29, 2023
How other firms rate ALNY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Truist Securities | Hold | $225 | Nov 2, 2026 |
| Bernstein | Mkt Perform | $199 | Oct 30, 2026 |
| Raymond James | Outperform | $315 | Oct 30, 2026 |
| Stifel | Hold | $225 | Oct 29, 2026 |
| UBS | Buy | $354 | Oct 15, 2026 |
| BMO Capital Markets | Outperform | $318 | Aug 19, 2026 |
| Citigroup | Buy | $380 | May 19, 2026 |
| Jefferies | Hold | $330 | Mar 16, 2026 |
| Barclays | Overweight | $527 | Jan 28, 2026 |
| Oppenheimer | Outperform | $500 | Jan 7, 2026 |
Questions about Raymond James and ALNY
- What is Raymond James's price target for ALNY?
- Raymond James's latest stated price target for Alnylam Pharmaceuticals Inc. (ALNY) is $315, from its action on Oct 30, 2026.
- What is Raymond James's rating on ALNY?
- Raymond James rates ALNY Outperform, a bullish rating, as of Oct 30, 2026.
- When did Raymond James last change its view on ALNY?
- On Oct 30, 2026, Raymond James downgrades to Outperform from Strong Buy, price target $315.
- How does Raymond James's ALNY target compare with other analysts?
- Across 10 firms with a ALNY price target in the last 12 months, the median target is $324. Raymond James's $315 is 3% below that.
More ALNY rating histories
- BMO Capital Markets3
- Oppenheimer4
- Wolfe Research3
- Goldman Sachs3
- Morgan Stanley8
- Leerink Partners3
- Piper Sandler3
All Raymond James ratingsALNY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.